why choose us

First received: September 12, 2022

Clinical Trial: A Feasibility Trial to Investigate the Safety and Between-group Effect Size of Stimulan-VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis of the Forefoot.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetic Foot Osteomyelitis

Study Type: INTERVENTIONAL


Official Title: A Multi-center, Randomized, Controlled Feasibility Trial of Stimulan-VG and Debridement With an Abbreviated Course of Systemic Antibiotics to Debridement and a Full Course of Systemic Antibiotics for

Brief Summary: The purpose of this trial is to evaluate the safety and between-group effect size of Stimulan-VG compared to SoC treatment in patients with diabetic foot osteomyelitis (DFO) of the forefoot.

Read more